Estrella Immunopharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
/ 
Frequently asked questions
To buy Estrella Immunopharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Estrella Immunopharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Estrella Immunopharma Inc. is ESLA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Estrella Immunopharma Inc. has its primary listing on NASDAQ (Small cap). You can trade Estrella Immunopharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Estrella Immunopharma Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Estrella Immunopharma Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Estrella Immunopharma Inc..